In Brief: SmithKline Beecham
This article was originally published in The Tan Sheet
Executive Summary
SmithKline Beecham: Howard Pien to president, pharmaceuticals-North America, replacing Exec VP-Pharmaceuticals Jerry Karabelas. The worldwide responsibility held by Karabelas has been narrowed to a focus on North America for Pien; international business likely will be overseen by Chief Operating Officer J.P. Garnier. Karabelas has been chosen as head of Novartis' healthcare operations and CEO of Novartis pharmaceuticals. In addition to heading the Rx business, Karabelas will oversee consumer health, Ciba Vision and the generic drug business...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning